Functional reprogramming of regulatory T cells in the absence of Foxp3


Charbonnier L., Cui Y., Stephen-Victor E., Harb H., Lopez D., Bleesing J. J., ...Daha Fazla

NATURE IMMUNOLOGY, cilt.20, sa.9, ss.1208-1226, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 9
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1038/s41590-019-0442-x
  • Dergi Adı: NATURE IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1208-1226
  • Marmara Üniversitesi Adresli: Evet

Özet

Regulatory T cells (T-reg cells) deficient in the transcription factor Foxp3 lack suppressor function and manifest an effector T (T-eff) cell-like phenotype. We demonstrate that Foxp3 deficiency dysregulates metabolic checkpoint kinase mammalian target of rapamycin (mTOR) complex 2 (mTORC2) signaling and gives rise to augmented aerobic glycolysis and oxidative phosphorylation. Specific deletion of the mTORC2 adaptor gene Rictor in Foxp3-deficient T-reg cells ameliorated disease in a Foxo1 transcription factor-dependent manner. Rictor deficiency re-established a subset of T-reg cell genetic circuits and suppressed the T-eff cell-like glycolytic and respiratory programs, which contributed to immune dysregulation. Treatment of T-reg cells from patients with FOXP3 deficiency with mTOR inhibitors similarly antagonized their T-eff cell-like program and restored suppressive function. Thus, regulatory function can be re-established in Foxp3-deficient T-reg cells by targeting their metabolic pathways, providing opportunities to restore tolerance in T-reg cell disorders.